Ignite Creation Date:
2024-05-06 @ 1:28 PM
Last Modification Date:
2024-10-26 @ 1:14 PM
Study NCT ID:
NCT04031885
Status:
TERMINATED
Last Update Posted:
2021-08-24
First Post:
2019-07-23
Brief Title:
A Study of Abemaciclib LY2835219 in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive HER2 Negative Metastatic Breast Cancer
Sponsor:
Organization:
Eli Lilly and Company